Risks, Benefits, and the Optimal Time to Resume Deep Vein Thrombosis Prophylaxis in Patients with Intracranial Hemorrhage

Introduction It is common to start all patients on chemical prophylaxis for deep vein thrombosis (DVT) in order to decrease the risk of venous thromboembolism (VTE) and the associated adverse effects, including the potential for fatal pulmonary embolism (PE). There is no consensus in the literature...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cureus
Päätekijät: Farr, Saman, Toor, Harjyot, Patchana, Tye, Podkovik, Stacey, Wiginton, James G, Sweiss, Raed, Wacker, Margaret Rose, Miulli, Dan E
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Cureus 2019
Aiheet:
Quality Improvement
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6827698/
https://ncbi.nlm.nih.gov/pubmed/31754562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.5827
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia